Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.56
+0.92 (3.89%)
Jul 9, 2026, 4:00 PM EDT - Market closed
Castle Biosciences Employees
Castle Biosciences had 942 employees as of March 31, 2026. The number of employees increased by 59 or 6.68% since the number was last reported on December 31, 2025.
Employees
942
Change
59
Growth
6.68%
Revenue / Employee
$360,849
Profits / Employee
-$13,622
Market Cap
744.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 942 | 59 | 6.68% | 942 | 0 |
| Dec 31, 2025 | 883 | 122 | 16.03% | 883 | 0 |
| Dec 31, 2024 | 761 | 151 | 24.75% | 761 | 0 |
| Dec 31, 2023 | 610 | 67 | 12.34% | 610 | 0 |
| Dec 31, 2022 | 543 | 198 | 57.39% | 542 | 1 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| GRAIL | 910 |
| CareDx | 765 |
| Adaptive Biotechnologies | 624 |
CSTL News
- 1 day ago - Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026 - PRNewsWire
- 14 days ago - Castle Biosciences’ i31-SLNB outperforms MIA nomogram in lymph node biopsy - TheFly
- 14 days ago - DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy - PRNewsWire
- 15 days ago - Roth starts Castle Biosciences at Buy, notes quality revenue growth outlook - TheFly
- 15 days ago - Castle Biosciences initiated with a Buy at Roth Capital - TheFly
- 17 days ago - Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal - PRNewsWire
- 21 days ago - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 24 days ago - Castle Biosciences’ TissueCypher Test surpasses 100,000 orders - TheFly